Trial · NCT03586934
Multimodal Analgesia in Shoulder Arthroplasty
NCT03586934, Phase 3, Withdrawn, Rush University Medical Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Multimodal Analgesia in Shoulder Arthroplasty. Trials, record NCT03586934. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03586934
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Multimodal Analgesia in Shoulder Arthroplasty
- NCT number
- NCT03586934
- Status
- Withdrawn
- Phases
- Phase 3
- Enrollment
- 0 participants, actual
- Lead sponsor
- Rush University Medical Center
- Conditions
- Shoulder Pain, Opioid Use
- Interventions
Acetaminophen, Celecoxib 200mg, Celecoxib 400 mg, Ropivacaine, Ketorolac, Acetaminophen Injectable Product, Oxycodone, Tramadol, Morphine Injectable Solution, hydrocodone bitartrate and acetaminophen, Morphine, Oxycodone Hydrochloride, Meloxicam
- First posted
- 2018-07-16
- Last updated
- 2021-09-28
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Oxycodone tablets | From time of discharge until the date the subject is no longer using oxycodone or up 90 days after surgery, whichever came first | Number of tablets taken by patient after hospital discharge |
| Secondary | Patient Reported Outcome Measures | administered preoperatively, 6 weeks, 3 months | Standard shoulder surveys assessing activity and pain |
| Secondary | Shoulder range of motion and strength testing | tested as appropriate at 3 weeks, 6 weeks, and 3 months | postoperative shoulder range of motion and strength testing |
| Secondary | Complications | Up to 90 days | Deep vein thrombosis, pulmonary embolism, return to surgery, hospital readmission, superficial or deep infection, periprosthetic fracture, cerebrovascular accident or transient ischemic attack, dislocation, and opioid withdrawal |
| Secondary | Pain Score | From time of randomization until the date of hospital discharge, assessed up to 90 days after surgery. | Inpatient Pain Score- Visual Analog Scale (VAS) for pain. This is a standard pain evaluation scale rating pain 0 (no pain) to 10 (worst imaginable pain). Lower scores indicate a better outcome. |
| Secondary | Postoperative Inpatient Opioid Utilization | From time of randomization until the date of hospital discharge, assessed up to 90 days after surgery. | Amount of opioid medications taken by patient in hospital |
| Secondary | Long-term Pain Scores | Assessed on a weekly basis from the time of discharge up to 90 days after surgery. | Pain scores of patient after hospital discharge- Visual Analog Scale (VAS) for pain. This is a standard pain evaluation scale rating pain 0 (no pain) to 10 (worst imaginable pain). Lower scores indicate a better outcome. |
| Other | Illinois Prescription Monitoring Program (IPMP) | Up to 90 days | Patient compliance with IPMP |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers7
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03586934
GET https://conductscience.org/api/trials/v1/NCT03586934/registered